Regeneron Pharmaceuticals Basic EPS 2010-2024 | REGN

Regeneron Pharmaceuticals basic eps for the twelve months ending September 30, 2024 was $43.23, a 15.74% increase year-over-year.

  • Regeneron Pharmaceuticals annual basic eps for 2023 was $0.037B, a 8.54% decline from 2022.
  • Regeneron Pharmaceuticals annual basic eps for 2022 was $0.041B, a 46.98% decline from 2021.
  • Regeneron Pharmaceuticals annual basic eps for 2021 was $0.076B, a 134% increase from 2020.

Regeneron Pharmaceuticals Basic EPS 2010-2024 | REGN

  • Regeneron Pharmaceuticals annual basic eps for 2023 was $0.037B, a 8.54% decline from 2022.
  • Regeneron Pharmaceuticals annual basic eps for 2022 was $0.041B, a 46.98% decline from 2021.
  • Regeneron Pharmaceuticals annual basic eps for 2021 was $0.076B, a 134% increase from 2020.